Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 17:00
955.25
2.2 (0.23%)
VOLUME 35,908
LIVE
NSE
Apr 17, 17:00
955.65
2.95 (0.31%)
VOLUME 469,473
News on Lupin
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Bull's Eye: Buy Adani Port, NIIT Tech, Lupin, Raymond 

9.14 am | 17 Apr 2014 |  Source: CNBC-TV18

Nooresh Mirani, CEO Analyse India, Nooreshtech.co.in recommends buying JB Chemicals and Pharmaceuticals for a target price of Rs 155 and HCL Infosyste...

Lupin pulls over 9,000 bottles of anti-infective Suprax

2.16 pm | 15 Apr 2014 |  Source: Reuters

The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year b...

Stocks in news: Infy, AstraZeneca, United Spirits, Bharti

8.11 am | 15 Apr 2014 |  Source: CNBC-TV18

Infosys | DCB Bank | CMC | Gruh Finance | Tata Motors | Tata Power | AstraZeneca Pharma | United Spirits | Tata Steel | Coal India | Bharti Airtel | A...

Religare expects Q4 to be mixed-bag, picks top sector bets 

11.56 am | 12 Apr 2014 |  Source: CNBC-TV18

Tirthankar Patnaik bearish on financials and public sector lenders, but State Bank of India is the stock from the PSB pack which he likes....

Prefer Lupin, Biocon: Sharmila Joshi 

2.46 pm | 10 Apr 2014 |  Source: CNBC-TV18

Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer Biocon, Ipca Laboratories or Lupin at current levels....

Lupin gets USFDA approval for diabetes management drug

4.40 pm | 09 Apr 2014 |  Source: PTI

Lupin said its US subsidiary, Lupin Pharmaceuticals Inc has received final approval for its Pioglitazone tablets from the US Food and Drugs Administra...

Lupin receives FDA approval for Generic Actos tablets

2.20 pm | 09 Apr 2014 |  Source: Moneycontrol.com

Lupin announced today that it has received final approval for its Pioglitazone Tablets USP, 15 mg, 30 mg, and 45 mg from the United States Food and Dr...

Go long in Lupin, advises Ashish Chaturmohta 

1.58 pm | 04 Apr 2014 |  Source: CNBC-TV18

According to Ashish Chaturmohta of Fortune Equity Brokers, one may go long in Lupin with a target of Rs 1030....

Buy Cipla 400 Call, says VK Sharma 

11.00 am | 04 Apr 2014 |  Source: CNBC-TV18

VK Sharma of HDFC Securities is of the view that one may buy Cipla 400 Call at Rs 10....

Pharma cos may see healthy earnings growth in Q4FY14: CLSA

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

Most companies are expected to report some forex gains on hedges and foreign liabilities given the slight strengthening of rupee Q-o-Q, CLSA said....

Buy Lupin; target of Rs 1080: Emkay

1.27 pm | 28 Mar 2014 |  Source: Moneycontrol.com

Brokerage house Emkay Global Financial Services is bullish on Lupin and has recommended buy rating on the stock with a target price of Rs 1080 in its ...

Lupin eyes Brazil after Mexico-Lab Grin acquisition: MD 

4.54 pm | 27 Mar 2014 |  Source: CNBC-TV18

The Mexican market is about USD 13 billion. The generic and the branded generic market is all growing 20-25 percent, says Nilesh Gupta....

Lupin buys Mexico's Laboratorios Grin; enters LATAM mkt

2.55 pm | 27 Mar 2014 |  Source: PTI

Incorporated in 1955, Grin is a speciality pharmaceutical company engaged in the development, manufacturing and commercialisation of branded ophthalmi...

Lupin acquires Laboratorios Grin S.A. De C.V., Mexico

1.20 pm | 27 Mar 2014 |  Source: Moneycontrol.com

Pharma Major Lupin Limited announced today the acquisition of 100 percent equity stake in Laboratorios Grin, S.A. De C.V. (Grin), Mexico, subject to ...

Prefer Sun Pharma, Lupin: Hemant Thukral 

12.22 pm | 27 Mar 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money is of the view that one may look at Sun Pharmaceutical Industries and Lupin from the pharmaceutical space....

Here’s how market performed during UPA-2 regime 

10.37 pm | 26 Mar 2014 |  Source: CNBC-TV18

Since the UPA-2 came to power, wealth creation on the NSE stands at 35 lakh crore rupees with the nifty gaining 80 percent. But in dollar terms, that'...

Keep Lupin in portfolio, says Amit Gupta 

11.44 am | 26 Mar 2014 |  Source: CNBC-TV18

Amit Gupta, head-derivatives at ICICI Direct is of the view that one may keep Lupin in the portfolio. "Downsides seem to be limited. Even if market re...

Go long in Lupin; short Aurobindo Pharma: Chaturmohta 

1.44 pm | 25 Mar 2014 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Broker recommends going long in Lupin with a target of Rs 1010-1020....

Sun Pharma, Lupin top picks: Ambareesh Baliga 

4.56 pm | 24 Mar 2014 |  Source: CNBC-TV18

According to Ambareesh Baliga, Managing Partner-Global Wealth Management at Edelweiss Financial Services, one may pick Sun Pharmaceutical Industries a...

Lupin launches Generic Niaspan tablets in US

2.03 pm | 21 Mar 2014 |  Source: Moneycontrol.com

Lupin announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Niacin Extended Release Tablets USP, 500 mg, 750 mg, 1000 mg...

1 2 3 4 5 6
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.